NVO
Novo Nordisk A/S
Novo Nordisk A/S 13F Holders
NVO Stock Ownership Activity
- # of activities:
- 3
- AVG reported price*:
- $69.02
- Current price*:
- -29.09%($48.94)
3 value investing gurus have made changes to the Novo Nordisk A/S (NVO) position according to the gurus' 2025 Q2 SEC quarterly report(s). NVO has been bought (as a new position) by 1 guru(s), the number of NVO shares has been increased by 1, decreased by 1 super investor(s).
Which gurus or hedge funds bought NVO in 2025 Q2?
According to the 2025 Q2 SEC filing(s) Novo Nordisk A/S (NVO) has been bought by 2 gurus / funds: Parnassus Endeavor Fund (added shares +9.23%) and Sarah Ketterer - Causeway Capital Management (new buy).
To see more about who is investing in Novo Nordisk A/S (NVO), please go to the NVO ownership page.
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* AVG reported price: weighted average based on position sizes. Larger holdings have proportionally more influence on the average. This doesn't represent the actual buy or sell price. It is the split-adjusted average price of the securities as of the last day of the reported period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.